Drug
Sezaby
Sezaby: highest development phase Post-Market, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sezaby NCT07923734 | Post-Market | Neonatal Seizure |
Latest
No recent events.
Follow Sezaby on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.